These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21248661)

  • 1. NAFLD recurrence in liver transplant recipients.
    Dureja P; Mellinger J; Agni R; Chang F; Avey G; Lucey M; Said A
    Transplantation; 2011 Mar; 91(6):684-9. PubMed ID: 21248661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease after liver transplantation: a case of nurture and nature.
    Ong J; Younossi ZM
    Am J Gastroenterol; 2010 Mar; 105(3):621-3. PubMed ID: 20203643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
    Mindikoglu AL; Regev A; Casanova-Romero PY; Bejarano PA; Martinez EJ; Tzakis AG; Schiff ER
    Transplant Proc; 2006 Jun; 38(5):1440-4. PubMed ID: 16797327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience.
    Heuer M; Kaiser GM; Kahraman A; Banysch M; Saner FH; Mathé Z; Gerken G; Paul A; Canbay A; Treckmann JW
    Digestion; 2012; 86(2):107-13. PubMed ID: 22846254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo nonalcoholic fatty liver disease after liver transplantation.
    Seo S; Maganti K; Khehra M; Ramsamooj R; Tsodikov A; Bowlus C; McVicar J; Zern M; Torok N
    Liver Transpl; 2007 Jun; 13(6):844-7. PubMed ID: 17029282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
    Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
    Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome.
    El Atrache MM; Abouljoud MS; Divine G; Yoshida A; Kim DY; Kazimi MM; Moonka D; Huang MA; Brown K
    Clin Transplant; 2012; 26(5):E505-12. PubMed ID: 23061759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical associations of posttransplant fatty liver disease.
    Lim LG; Cheng CL; Wee A; Lim SG; Lee YM; Sutedja DS; Da Costa M; Prabhakaran K; Wai CT
    Liver Int; 2007 Feb; 27(1):76-80. PubMed ID: 17241384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
    Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
    Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent non-alcoholic steatohepatitis in a living related liver transplant recipient.
    Saab S; Cho D; Lassman RC; Gajjar NA; Ghobrial M; Busuttil RW
    J Hepatol; 2005 Jan; 42(1):148-9. PubMed ID: 15629523
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
    Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
    Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation.
    Patil DT; Yerian LM
    Liver Transpl; 2012 Oct; 18(10):1147-53. PubMed ID: 22740341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for primary biliary cirrhosis: results of aggressive corticosteroid withdrawal.
    Campsen J; Zimmerman M; Trotter J; Wachs M; Bak T; Steinberg T; Kaplan M; Kam I
    Transplant Proc; 2009 Jun; 41(5):1707-12. PubMed ID: 19545712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and liver transplantation.
    Hanouneh IA; Zein NN
    Minerva Gastroenterol Dietol; 2010 Sep; 56(3):297-304. PubMed ID: 21037547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid recurrence of nonalcoholic fatty liver disease after transplantation in a child with hypopituitarism and hepatopulmonary syndrome.
    Jonas MM; Krawczuk LE; Kim HB; Lillehei C; Perez-Atayde A
    Liver Transpl; 2005 Jan; 11(1):108-10. PubMed ID: 15690545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".
    Dumortier J; Giostra E; Belbouab S; Morard I; Guillaud O; Spahr L; Boillot O; Rubbia-Brandt L; Scoazec JY; Hadengue A
    Am J Gastroenterol; 2010 Mar; 105(3):613-20. PubMed ID: 20040915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of nonalcoholic fatty liver disease in adults.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G; Babini M
    Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.